<?xml version="1.0" encoding="UTF-8"?>
<ref id="B13">
 <label>13.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wollacott</surname>
    <given-names>AM</given-names>
   </name>
   <name>
    <surname>Boni</surname>
    <given-names>MF</given-names>
   </name>
   <name>
    <surname>Szretter</surname>
    <given-names>KJ</given-names>
   </name>
   <name>
    <surname>Sloan</surname>
    <given-names>SE</given-names>
   </name>
   <name>
    <surname>Yousofshahi</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Viswanathan</surname>
    <given-names>K</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Safety and upper respiratory pharmacokinetics of the hemagglutinin stalk-binding antibody VIS410 support treatment and prophylaxis based on population modeling of seasonal influenza A outbreaks</article-title>. 
  <source>EBioMedicine</source>. (
  <year>2016</year>) 
  <volume>5</volume>:
  <fpage>147</fpage>â€“
  <lpage>55</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.ebiom.2016.02.021</pub-id>
  <?supplied-pmid 27077121?>
  <pub-id pub-id-type="pmid">27077121</pub-id>
 </mixed-citation>
</ref>
